Programme
HKT
Lecture Theatre 1A
Lecture Theatre 1B
Room 209
- 09:00
- 09:10
- 09:20
- 09:30
- 09:40
- 09:50
- 10:00
- 10:10
- 10:20
- 10:30
- 10:40
- 10:50
- 11:00
- 11:10
- 11:20
- 11:30
- 11:40
- 11:50
- 12:00
- 12:10
- 12:20
- 12:30
- 12:40
- 12:50
- 13:00
- 13:10
- 13:20
- 13:30
- 13:40
- 13:50
- 14:00
- 14:10
- 14:20
- 14:30
- 14:40
- 14:50
- 15:00
- 15:10
- 15:20
- 15:30
- 15:40
- 15:50
- 16:00
Lecture Theatre 1A
-
09:00-10:3009:00-10:30Irritable Bowel Syndrome: Food, Poop and DrugsBy: Paul MOAYYEDILecture Theatre 1AIrritable Bowel Syndrome: Food, Poop and Drugs09:00-09:3009:30-10:00FMT in IBS management: ready for prime time?Paul MOAYYEDIMcMaster University, Hamilton, Canada
- Assistant Dean of Research
10:00-10:30New drugs in IBSJustin Wu (Hong Kong) -
10:30-11:00
-
11:00-12:3011:00-12:30GI cancer: from prevention to cureBy: Raja AFFENDILecture Theatre 1AGI cancer: from prevention to cure11:00-11:30Non-invasive biomarkers for colorectal cancer: recent guidelinesRaja AFFENDINational University of Malaysia Medical Centre, Kuala Lumpur, Malaysia
- Consultant Gastroenterologist
- Professor of Medicine
11:30-12:00Prevention of GI cancer: dream or reality?Rashid Lui (Hong Kong)12:00-12:30What’s new in upper GI cancer treatment?Kai-chun Wu (China) -
12:30-13:3012:30-13:30LunchLecture Theatre 1ALunch
-
13:30-14:3013:30-14:30Lunch Symposium (C)Lecture Theatre 1ALunch Symposium (C)
-
14:30-16:0014:30-16:00COVID-19 and the GUT: lessons learntBy: Gilaad KAPLAN, Martin WONGLecture Theatre 1ACOVID-19 and the GUT: lessons learnt14:30-15:00Gut microbiome and vaccine responseHein Tun (Hong Kong)15:00-15:30COVID-19 vaccine and immunosuppressants: chicken or egg?Gilaad KAPLANUniversity of Calgary, Canada
- Professor of Medicine, Division of Gastroenterology and Hepatology, Cumming School of Medicine
15:30-16:00Balancing your gut microbiome to fight COVID-19: what’s the evidence?Martin WONGThe Chinese University of Hong Kong, Hong Kong- Professor, JC School of Public Health and Primary Care, Faculty of Medicine
- Professor (by courtesy), Department of Sports Science and Physical Education
Peking Union Medical College, China- Adjunct Professor, School of Public Health
Peking University, China- Adjunct Professor of Global Health, School of Public Health
Lecture Theatre 1B
-
09:00-10:3009:00-10:30State Key Lab Meeting (3) - Microbiome and host responseBy: Rhonda SOUZALecture Theatre 1BState Key Lab Meeting (3) - Microbiome and host response09:00-09:30Microbiome in GI cancerEmad El-Omar (Australia)09:30-10:00Genetic stability and individual specificity of the human gut microbiomeJingyuan Fu (The Netherlands)10:00-10:30The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinomaRhonda SOUZABaylor University Medical Center, Dallas, USA
- Co-Director, Center for Esophageal Diseases
Baylor Scott & White Research Institute, Dallas, USA- Co-Director, Center for Esophageal Research
Texas A&M Health Science Center College of Medicine, USA- Adjunct Professor of Medicine
-
10:30-11:00
-
11:00-12:3011:00-12:30State Key Lab Meeting (4) - Microbiome and cancer therapyLecture Theatre 1BState Key Lab Meeting (4) - Microbiome and cancer therapy11:00-11:30Microbiome and anti-cancer therapyEran Elinav (Germany)11:30-12:00Enterococcus and cancer immunotherapyHoward Hang (USA)12:00-12:30Targeting microbiome for cancer prevention/treatmentChristian Jobin (USA)
-
12:30-13:3012:30-13:30LunchLecture Theatre 1BLunch
-
13:30-14:3013:30-14:30Lunch Symposium (D)Lecture Theatre 1BLunch Symposium (D)13:30-14:30
-
14:30-16:0014:30-16:00General hepatology updatesBy: Roberto de FRANCHISLecture Theatre 1BGeneral hepatology updates14:30-15:0015:00-15:30Updates in autoimmune liver diseasesMichael Manns (Germany)15:30-16:00What is new in the Baveno VII consensus?Roberto de FRANCHISUniversity of Milan, Italy
- Emeritus Professor of Medicine
Room 209
-
09:00-10:3009:00-10:30Asian Frontiers in GI Endoscopy (AFGIE) SymposiumBy: Manoel GALVAO NETO, Louis LAU, Raymond TANGRoom 209Asian Frontiers in GI Endoscopy (AFGIE) Symposium09:00-09:22Endoscopic tissue approximation in management of GI diseasesManoel GALVAO NETOABC Medical School, Santo Andre, Brazil
- Affiliate Professor of Surgery
Herbert Wertheim College of Medicine, Florida International University, USA- Clinical Assistant Professor of Surgery
09:22-09:45Current status of EUS-guided portal pressure gradient measurementMarvin Ryou (USA)09:45-10:07Tricks to enhance adenoma detection rate in colonoscopy: second look, mucosal exposure device, or AI?Louis LAUThe Chinese University of Hong Kong, Hong Kong- Assistant Professor (Clinical), Department of Medicine & Therapeutics
Prince of Wales Hospital, Hong Kong- Honorary Resident Specialist
10:07-10:30Troubleshooting difficult bile duct access: advanced ERCP cannulation techniques or EUS guided biliary access?Raymond TANGThe Chinese University of Hong Kong, Hong Kong- Director, S.H. Ho Center for Digestive Health
- Assistant Professor, Department of Medicine and Therapeutics
Prince of Wales Hospital, Hong Kong- Deputy Director, Endoscopy Center
Raymond Tang (Hong Kong) -
10:30-11:00
-
11:00-12:3011:00-12:30Towards control of viral hepatitisRoom 209Towards control of viral hepatitis11:00-11:30Eliminating HCV in lockdownAlexander Thompson (Australia)11:30-12:00Disease burden of viral hepatitis in Hong Kong – should we treat more?Jimmy Lai (Hong Kong)12:00-12:30Will immunomodulatory treatment contribute to HBV elimination?Lai Wei (China)
Irritable Bowel Syndrome: Food, Poop and Drugs
State Key Lab Meeting (3) - Microbiome and host response
Asian Frontiers in GI Endoscopy (AFGIE) Symposium
09:22
Current status of EUS-guided portal pressure gradient measurement
09:45
GI cancer: from prevention to cure
State Key Lab Meeting (4) - Microbiome and cancer therapy
Towards control of viral hepatitis
Lunch Symposium (C)
COVID-19 and the GUT: lessons learnt
** Programme is subject to change without prior notice
